Payer+Provider's Health System Review
J&J pauses COVID-19 vaccine trial over participant’s ‘unexplained illness’
Higher margins and lower medical loss ratios present a challenge for insurers in setting premiums
October 13, 2020
Read the full post on Becker's Hospital Review - Healthcare News
